Sajad Zalzala wants to enable off-label uses of common drugs, like Metformin, to slow aging.
Ira Pastor, ideaXme longevity and aging ambassador and founder of Bioquark, interviews Ambassador Juan José Gómez Camacho, Mexico’s current Ambassador to Canada, and for the last 3 years, Mexico’s Permanent Representative of the United Nations in New York City.
Ira Pastor Comments:
Continue reading “International Co-operation to Ensure the Health of all the World’s Citizens” »
Steven Gundry, MD, author of The Longevity Paradox: How to Die Young at a Ripe Old Age, explains how he boosted patients’ lifespan and healthspan by combining conventional medicine with nutritional therapy.
Researchers are working to get to the bottom of longevity, unlocking the secrets to extending our lifespans well into our 100s… and beyond.
» Subscribe to Seeker! http://bit.ly/subscribeseeker
» Watch more How Close Are We | http://bit.ly/HCAWplaylist
» Follow Olivia on Instagram: instagram.com/OliviaPavcoG
Harvard Professor David Sinclair thinks longevity, or extending our lifespan, is the “greatest unsolved problem in biology.”
My mission is to drastically improve your life by helping you break bad habits, build and keep new healthy habits to make you the best version of yourself. I read the books and do all the research and share my findings with you!
This video is “Day 1” of RAADfest 2019 in Las Vegas. I discuss various products, companies & topics that are on display at RAADfest. I will do my best at RAADfest to interview longevity experts like James Strole, Bernadeane, Liz Parrish, Dr. Aubrey de Grey, Dr. Bill Andrews, Dr. Ed Park, Dr. Duncan Ross, Ben Goertzel, Bill Faloon and hopefully many more. I’ll bring you all the major updates from RAADfest!
I’ll be sharing daily RAADfest Roundups this week on my YouTube channel.
Continue reading “RAADfest Roundup Day 1, 2019, Las Vegas” »
At the Ending Age-Related Diseases 2019 Conference in New York City, we had the opportunity to interview Dr. Justin Rebo from the drug discovery biotech company BioAge.
BioAge is developing a drug discovery platform that uses machine learning and artificial intelligence to discover targets that have the potential to promote healthy lifespan (healthspan) by slowing down aging and the ill health that it brings.
As the vice president of in-vivo biology at BioAge, Dr. Rebo leads the company’s internal in-vivo platform to find and assess the viability of new druggable targets for aging diseases and biomedical regeneration. With considerable business as well as academic experience in the aging field under his belt, Justin joined the BioAge team in 2018.
A year old, and this video is titled with the “I-word”. But a very interesting talk.
It’s not every day that I get to post a video where I feel like I’m involved with something that may seriously improve and extend lives. I’m so grateful that somehow, I was brought into this process.
The Healthy Life Extension Society: https://heales.org
Follow us on Twitter : https://twitter.com/_LongLongLife_
Follow us on Facebook : https://www.facebook.com/longlonglifedotorg/
Follow us on Linkedin : https://www.linkedin.com/company/22311577
Our Website : http://www.longlonglife.org
The idea that humans should merge with AI is very much in the air these days. It is offered both as a way for humans to avoid being outmoded by AI in the workplace, and as a path to superintelligence and immortality. For instance, Elon Musk recently commented that humans can escape being outmoded by AI by “having some sort of merger of biological intelligence and machine intelligence.”1 To this end, he’s founded a company, Neuralink. One of its first aims is to develop “neural lace,” an injectable mesh that connects the brain directly to computers. Neural lace and other AI-based enhancements are supposed to allow data from your brain to travel wirelessly to one’s digital devices or to the cloud, where massive computing power is available.
For many transhumanists, uploading is key to the mind-machine merger.
Perhaps these sorts of enhancements will turn out to be beneficial, but to see if this is the case, we will need to move beyond all the hype. Policymakers, the public, and even AI researchers themselves need a better idea of what is at stake. For instance, if AI cannot be conscious, then if you substituted a microchip for the parts of the brain responsible for consciousness, you would end your life as a conscious being. You’d become what philosophers call a “zombie”—a nonconscious simulacrum of your earlier self. Further, even ifmicrochips could replace parts of the brain responsible for consciousness without zombifying you, radical enhancement is still a major risk. After too many changes, the person who remains may not even be you. Each human who enhances may, unbeknownst to them, end their life in the process.
